CIBC World Market
LGND icon

CIBC World Market’s Ligand Pharmaceuticals LGND Stock Holding History

CIBC World Market’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,630
Closed -$4.85M – 1551
2025
Q4 		$4.85M Sell
25,630
-33,501
-57% -$6.44M 0.01% 577
2025
Q3 		$10.5M Buy
59,131
+6,209
+12% +$923K 0.02% 401
2025
Q2 		$6.02M Sell
52,922
-20,692
-28% -$2.21M 0.01% 484
2025
Q1 		$7.74M Sell
73,614
-8,794
-11% -$994K 0.02% 400
2024
Q4 		$8.83M Sell
82,408
-1,719
-2% -$194K 0.02% 370
2024
Q3 		$8.42M Buy
+84,127
New +$8.47M 0.02% 364

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

CIBC World Market's LGND Position: Q1 2026 in Review

CIBC World Market sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 25,630 shares — an estimated $4.85M sold.

CIBC World Market first reported a position in LGND in Q3 2024 and held it in 6 quarters. The position peaked at $10.5M in Q3 2025. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • CIBC World Market reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • CIBC World Market sold 25,630 Ligand Pharmaceuticals shares in Q1 2026, an estimated $4.85M.
  • CIBC World Market first reported a position in Ligand Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • CIBC World Market's Ligand Pharmaceuticals position peaked at $10.5M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.